Literature DB >> 22041434

Baclofen toxicity in patients with advanced nephropathy: proposal for new labeling.

Amr El-Husseini1, Alberto Sabucedo, Jorge Lamarche, Craig Courville, Alfredo Peguero.   

Abstract

BACKGROUND: Despite several reports in the literature of baclofen toxicity in patients with renal dysfunction, the drug is being used for many patients.
METHODS: Herein we report a case of baclofen-induced encephalopathy in a patient with pre-end-stage renal disease and review the literature regarding the magnitude of baclofen toxicity in patients with renal insufficiency. A Medline search for studies in English was performed. Twenty-one case reports involving 41 patients (including our patient) were identified.
RESULTS: The majority of patients were elderly (62.5% above 60 years) males (56.3%) on dialysis (62.9%). Neurotoxicities were almost always present at presentation. Manifestations of baclofen toxicity usually started 2-3 days after starting baclofen; however, periods as long as 16 weeks have been reported. The daily dose of baclofen ranged from 5 to 60 mg with a mean dose of 20 mg. Hemodialysis (HD) was the most common treatment modality used for drug elimination (65.7%). The recovery time ranged from 2 h in patients who received HD, to 8 days with conservative treatment.
CONCLUSION: The literature does not mention a clear recommendation about baclofen safety and dose adjustment, or a minimum level of kidney function below which the drug should not be used.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22041434     DOI: 10.1159/000333247

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  10 in total

1.  Baclofen Toxicity Causing Acute, Reversible Dyskinesia.

Authors:  Matthew T Niehaus; Nicole C Elliott; Kenneth D Katz
Journal:  J Med Toxicol       Date:  2016-05-27

2.  Iatrogenic Baclofen Neurotoxicity in ESRD: Recognition and Management.

Authors:  John K Roberts; Scott Westphal; Matthew A Sparks
Journal:  Semin Dial       Date:  2015-06-21       Impact factor: 3.455

3.  Baclofen-Induced Encephalopathy in End Stage Renal Disease.

Authors:  Andrew Meillier; Cara Heller; Shyam Patel
Journal:  Case Rep Med       Date:  2015-07-29

4.  Baclofen-Related Neurotoxicity: Implication in a Fatality Associated With Hepatorenal Syndrome.

Authors:  Larry K Golightly; Lauren E Grecheck; Ike I Kim
Journal:  Clin Med Insights Case Rep       Date:  2017-06-19

5.  Single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report.

Authors:  Emad Khazneh; Alaa Shamlawi; Kamel Jebrin; Zakaria Hamdan; Osama Sawalmeh
Journal:  BMC Nephrol       Date:  2018-12-11       Impact factor: 2.388

6.  Baclofen-induced neurotoxicity in chronic kidney disease: Is there a safe dose?

Authors:  Prem P Varma; Geet Bajpai
Journal:  Indian J Nephrol       Date:  2022-01-05

7.  A Small Dose Can Cause a Major Problem.

Authors:  Pooja Patel; Adriana Yates Munar; George Michel
Journal:  Cureus       Date:  2022-02-23

Review 8.  Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review.

Authors:  Pascal Valentin Fischler; Michael Soyka; Erich Seifritz; Jochen Mutschler
Journal:  Front Pharmacol       Date:  2022-10-03       Impact factor: 5.988

9.  Clinical effectiveness of baclofen for the treatment of alcohol dependence: a review.

Authors:  Jessica L Brennan; Jonathan G Leung; Jane P Gagliardi; Sarah K Rivelli; Andrew J Muzyk
Journal:  Clin Pharmacol       Date:  2013-07-03

10.  Electroacupuncture for decorticate rigidity of the upper limbs in a patient with anoxic brain damage.

Authors:  Woosang Jung; Seungwon Kwon; Seonguk Park; Sangkwan Moon; Jungmi Park; Changnam Ko; Kiho Cho
Journal:  Case Rep Med       Date:  2013-10-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.